Product NDC: | 0597-0140 |
Proprietary Name: | Tradjenta |
Non Proprietary Name: | linagliptin |
Active Ingredient(s): | 5 mg/1 & nbsp; linagliptin |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET, FILM COATED |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0597-0140 |
Labeler Name: | Boehringer Ingelheim Pharmaceuticals, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA201280 |
Marketing Category: | NDA |
Start Marketing Date: | 20110509 |
Package NDC: | 0597-0140-70 |
Package Description: | 1 BLISTER PACK in 1 CARTON (0597-0140-70) > 7 TABLET, FILM COATED in 1 BLISTER PACK |
NDC Code | 0597-0140-70 |
Proprietary Name | Tradjenta |
Package Description | 1 BLISTER PACK in 1 CARTON (0597-0140-70) > 7 TABLET, FILM COATED in 1 BLISTER PACK |
Product NDC | 0597-0140 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | linagliptin |
Dosage Form Name | TABLET, FILM COATED |
Route Name | ORAL |
Start Marketing Date | 20110509 |
Marketing Category Name | NDA |
Labeler Name | Boehringer Ingelheim Pharmaceuticals, Inc. |
Substance Name | LINAGLIPTIN |
Strength Number | 5 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Dipeptidyl Peptidase 4 Inhibitors [MoA],Dipeptidyl Peptidase 4 Inhibitor [EPC] |